Mezion, Stock Price -1.66% at This Hour... 88,116 Shares Net Bought by Individuals in Last 5 Days

Mezion is trading at 183,500 KRW as of 9:30 AM on the 2nd, down 1.66% from the previous day. The trading volume is 58,123 shares, which is about 7.45% of the previous day's volume. Mezion is known as a company specializing in new drug development.

On July 1, Shin Jae-hoon, a researcher at Hanwha Investment & Securities, announced a target price of 300,000 KRW for Mezion, stating that "Udenafil, a treatment for Fontan surgery, has been designated as a Fast Track and is scheduled to undergo Priority Review. The FDA will decide within 60 days whether to proceed with the review and will assign a PDUFA Goal Date."

Over the past five days, individual investors have net purchased 88,116 shares of Mezion, while foreigners and institutions have net sold 5,343 shares and 60,497 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.